Scotland Advances Cardiac and Neurological Research with First Photon-Counting CT Scanner

The University of Edinburgh has become the first institution in Scotland to install a photon-counting CT scanner, marking a significant advancement in medical imaging technology. The NAEOTOM Alpha, developed by Siemens Healthineers, was jointly funded by the University and the British Heart Foundation (BHF) [1]. This cutting-edge system promises to enhance both research and patient care across multiple organ systems.

A Step-Change in Imaging Technology

Unlike conventional CT scanners that convert X-rays into visible light before processing, the NAEOTOM Alpha utilizes photon-counting detectors. These detectors directly capture and count each individual X-ray photon, enabling the collection of more detailed information with each scan. This results in images with finer detail and clearer contrast than previously achievable [1].

Impact on Cardiovascular and Neurological Research

The fresh scanner will be instrumental in advancing research in cardiovascular and neurological conditions. Its ultra-high-resolution capabilities will allow scientists to visualize the heart, lungs, brain, and blood vessels with unprecedented detail. This enhanced visualization will support studies focused on improving early detection, risk assessment, and understanding disease progression [1].

Specifically, the scanner will play a central role in the SCOT-HEART 2 trial, a BHF-funded study investigating the utilize of coronary CT angiography for earlier heart attack risk identification [1]. Researchers will leverage the increased image detail to refine how complex conditions are visualized and measured, exploring new imaging biomarkers and evaluating treatment responses.

Expert Perspectives

Professor Michelle Williams, of cardiovascular imaging at the University of Edinburgh, stated, “This is the next generation of CT scanning. For the first time, we can see structures and processes in the body that were not previously visible. The ultra-high-resolution capabilities of the NAEOTOM Alpha will not only make existing diagnoses more accurate but also open entirely new avenues for discovery – transforming how we understand and study disease.” [1]

Carl Smith, business area lead for CT at Siemens Healthineers Great Britain and Ireland, added, “Photon-counting CT represents a fundamental shift in diagnostic imaging, delivering image clarity, richer data, and the potential to transform clinical decision making. This technology is about redefining the future of precision medicine. This is an exciting milestone, setting a benchmark for innovation that will influence future clinical practice across Scotland, the UK and internationally.” [1]

The University of Edinburgh and the British Heart Foundation

The University of Edinburgh is a leading center for cardiovascular research, supported by the British Heart Foundation (BHF) [2]. The BHF has a long history of funding research at the University, including a previous study utilizing a Biograph mCT™ PET-CT system from Siemens Healthcare to investigate heart disease [3]. The BHF also supports Centres of Research Excellence at other UK universities, including Leicester, Manchester, and University College London [4].